Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance

European Journal of Endocrinology

Volumn 157, Issue 1, 2007, Pages 63-68

  Stakos, Dimitrios A ^c   Schuster, Dara P ^a   Sparks, Elizabeth A ^a   Meis, Sophia Boudoulas ^a   Wooley, Charles F ^a   Osei, Kwame ^a   Boudoulas, Harisios ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL AORTA; ADULT; AFRICAN AMERICAN; AORTA DISEASE; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR RISK; DIABETIC PATIENT; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL VALUE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PULSE WAVE; ARTERIAL STIFFNESS; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; INSULIN METABOLISM; RELATIVE;

ADULT; AORTA; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HEART VENTRICLES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; ORGAN SIZE; RISK FACTORS;

EID: 34547486986     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0121     Document Type: Article

References (30)

1. Kannel WB & McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979 241 2035-2038.
2. Osei K, Rhinesmith S, Gaillard T & Schuster D. Is glycosylated hemoglobin Alc a surrogate for metabolic syndrome in non-diabetic, first-degree relatives of African-American patients with type 2 diabetes? Journal of Clinical Endocrinology and Metabolism 2003 88 4596-4601.
3. Khaw KT, Wareham N, Bingham S, Luben R, Welch A & Day N. Association of hemoglobin Alc with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Annals of Internal Medicine 2004 141 413-420.
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 3160-3167.
5. Sahn DJ, DeMaria A, Kisslo J & Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978 58 1072-1083.
6. Kallaras K, Sparks EA, Schuster DP, Osei K, Wooley CF & Boudoulas H. Cardiovascular effects of aging. interrelationships of aortic, left ventricular, and left atrial function. Herz 2001 26 129-139.
7. Boudoulas H. Determination of left ventricular mass in clinical practice. Journal of Heart Valve Disease 1997 6 222-227.
8. Boudoulas H & Wooley CF. Aortic function. In Functional Abnormalities of the Aorta, edn 1, ch 1, pp 17-22. Eds H Boudoulas, P Toutouzas & CF Wooley. New York: Futura Publishing, 1996.
9. Hirata K, Triposkiadis F, Sparks E, Bowen J, Wooley CF & Boudoulas H. The Marfan syndrome: abnormal aortic elastic properties. Journal of the American College of Cardiology 1991 18 57-63.
10. Bergman RN, Prager R, Volund A & Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycemic glucose clamp. Journal of Clinical Investigation 1987 79 790-800.
11. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Holman A & Witteman JC. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001 32 454-460.
12. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ & Boudoulas H. Aortic distensibility abnormalities in coronary artery disease. American Journal of Cardiology 1987 59 1300-1304.
13. Oren A, Vos LE, Uiterwaal CS, Gorissen WH, Grobbee DE & Bots ML. Aortic stiffness and carotid intima-media thickness: two independent markers of subclinical vascular damage in young adults. European Journal of Clinical Investigation 2003 33 949-954.
14. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P & Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001 37 1236-1241.
15. Safar ME, Levy BI & Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003 107 2864-2869.
16. Levy D, Garrison RJ, Savage DD, Karmel WB & Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine 1990 322 1561-1566.
17. Wautier JL & Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circulation Research 2004 95 233-238.
18. Angulo J, Sanchez-Ferrer CF, Peiro C, Marin J & Rodriguez-Manas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved. Hypertension 1996 28 583-592.
19. Brownlee M, Vlassara H, Kooney A, Ulrich P & Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986 232 1629-1632.
20. Singer DE, Nathan DM, Anderson KM, Wilson PW & Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992 41 202-208.
21. Yates AP & Laing I. Age-related increase in hemoglobin Alc and fasting plasmaglucose is accompanied by a decrease in beta cell function without change in insulin sensitivity: evidence from a cross-sectional study of hospital personnel. Diabetic Medicine 2002 19 254-258.
22. Harris MI, Flegal KM, Cowie C, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM & Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Survey 1988-1994. Diabetes Care 1998 21 518-524.
23. Ko GT, Chan JC, Woo J, Lau E, Young VT Chow CC, Li JK, So WY, Chan WB & Cockram CS. Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabetic Medicine 1998 15 573-578.
24. Osei K, Gaillard T & Schuster D. Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance. Diabetes Care 1999 22 1588-1590.
25. Meis SB, Schuster D, Gaillard T & Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethnicity and Disease 2006 16 830-836.
26. Sasso FC, Carbonara. O, Nasti R, Campana B, Marfella R, Torella M, Nappi G, Torella R & Cozzolino D. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA 2004 291 1857-1863.
27. Vitelli LL, Shahar E, Heiss G, McGovern PG, Brancati FL, Eckfeldt JH & Folsom AR. Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study. Diabetes Care 1997 20 1454-1458.
28. Sargeant LA, Khaw K-T, Bingham S, Day NE, Luben RN, Oakes S, Welch A & Wareham NJ. Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. European Journal of Clinical Nutrition 2001 55 342-348.
29. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A & Laakso M. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002 359 2072-2077.
30. Stakos D, Schuster DP, Sparks EA, Osei K, Wooley CF & Boudoulas H. Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study. Heart 2005 91 589-594.